172 related articles for article (PubMed ID: 34188151)
1. De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinoma.
Maruyama A; Sato Y; Nakayama J; Murai J; Ishikawa T; Soga T; Makinoshima H
Sci Rep; 2021 Jun; 11(1):13474. PubMed ID: 34188151
[TBL] [Abstract][Full Text] [Related]
2. Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition.
Shu Z; Li Z; Huang H; Chen Y; Fan J; Yu L; Wu Z; Tian L; Qi Q; Peng S; Wei C; Xie Z; Li X; Feng Q; Sheng H; Li G; Wei D; Shan C; Chen G
Oncogene; 2020 Aug; 39(35):5721-5733. PubMed ID: 32712628
[TBL] [Abstract][Full Text] [Related]
3. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
[TBL] [Abstract][Full Text] [Related]
4. Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
Doerr F; George J; Schmitt A; Beleggia F; Rehkämper T; Hermann S; Walter V; Weber JP; Thomas RK; Wittersheim M; Büttner R; Persigehl T; Reinhardt HC
Sci Rep; 2017 Nov; 7(1):15511. PubMed ID: 29138515
[TBL] [Abstract][Full Text] [Related]
5. A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cells.
Taricani L; Shanahan F; Malinao MC; Beaumont M; Parry D
PLoS One; 2014; 9(11):e111714. PubMed ID: 25375241
[TBL] [Abstract][Full Text] [Related]
6. Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer.
Chiappori AA; Zheng Z; Chen T; Rawal B; Schell MJ; Mullaney BP; Bepler G
J Thorac Oncol; 2010 Apr; 5(4):484-90. PubMed ID: 20107425
[TBL] [Abstract][Full Text] [Related]
7. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
Kim KB; Kim Y; Rivard CJ; Kim DW; Park KS
Cancer Res; 2020 Nov; 80(22):5051-5062. PubMed ID: 32973083
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
9. The anti-apoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma (SCLC) tumor growth.
Chiappetta G; Basile A; Barbieri A; Falco A; Rosati A; Festa M; Pasquinelli R; Califano D; Palma G; Costanzo R; Barcaroli D; Capunzo M; Franco R; Rocco G; Pascale M; Turco MC; De Laurenzi V; Arra C
Oncotarget; 2014 Aug; 5(16):6846-53. PubMed ID: 25149536
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.
Zhao Z; Liu J; Wang C; Wang Y; Jiang Y; Guo M
Int J Clin Exp Pathol; 2014; 7(11):7726-34. PubMed ID: 25550809
[TBL] [Abstract][Full Text] [Related]
11. Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication.
Foskolou IP; Jorgensen C; Leszczynska KB; Olcina MM; Tarhonskaya H; Haisma B; D'Angiolella V; Myers WK; Domene C; Flashman E; Hammond EM
Mol Cell; 2017 Apr; 66(2):206-220.e9. PubMed ID: 28416140
[TBL] [Abstract][Full Text] [Related]
12. P53 suppresses ribonucleotide reductase via inhibiting mTORC1.
He Z; Hu X; Liu W; Dorrance A; Garzon R; Houghton PJ; Shen C
Oncotarget; 2017 Jun; 8(25):41422-41431. PubMed ID: 28507282
[TBL] [Abstract][Full Text] [Related]
13. DLL3 is regulated by LIN28B and miR-518d-5p and regulates cell proliferation, migration and chemotherapy response in advanced small cell lung cancer.
Huang J; Cao D; Sha J; Zhu X; Han S
Biochem Biophys Res Commun; 2019 Jun; 514(3):853-860. PubMed ID: 31079917
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.
Kuo ML; Hwang HS; Sosnay PR; Kunugi KA; Kinsella TJ
Cancer J; 2003; 9(4):277-85. PubMed ID: 12967138
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
[TBL] [Abstract][Full Text] [Related]
16. ARHGEF19 regulates MAPK/ERK signaling and promotes the progression of small cell lung cancer.
Wang Z; Kan G; Sheng C; Yao C; Mao Y; Chen S
Biochem Biophys Res Commun; 2020 Dec; 533(4):792-799. PubMed ID: 32993957
[TBL] [Abstract][Full Text] [Related]
17. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.
Wael H; Yoshida R; Kudoh S; Hasegawa K; Niimori-Kita K; Ito T
Lung Cancer; 2014 Aug; 85(2):131-40. PubMed ID: 24888228
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AX.
Yang H; Luo J; Liu Z; Zhou R; Luo H
Cancer Invest; 2015 Apr; 33(4):126-36. PubMed ID: 25699650
[TBL] [Abstract][Full Text] [Related]
20. Lysine‑specific demethylase 2 contributes to the proliferation of small cell lung cancer by regulating the expression of TFPI‑2.
Cao Y; Guo C; Yin Y; Li X; Zhou L
Mol Med Rep; 2018 Jul; 18(1):733-740. PubMed ID: 29845195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
